Pharmaceuticals: Major
German companies operating in the same pharmaceuticals: major industry
The table below has German companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Novo Nordisk A/S Class B. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 606.71 B EUR | 640.4 EUR | +0.58% | 244 | 0.61 | 50.02 | 12.80 EUR | +71.29% | 0.77% | Health technology | Strong buy |
 JNJJohnson & Johnson | 363.97 B EUR | 151.70 EUR | +0.81% | 47 | 0.26 | 19.11 | 7.94 EUR | +22.89% | 2.87% | Health technology | Buy |
 4ABAbbVie, Inc. | 317.46 B EUR | 179.4 EUR | +0.34% | 0 | 0.00 | 100.57 | 1.78 EUR | −36.09% | 3.07% | Health technology | Buy |
 RHORoche Holding Ltd | 231.81 B EUR | 301.0 EUR | −0.07% | 0 | 0.00 | 23.95 | 12.57 EUR | −8.51% | 3.40% | Health technology | Neutral |
 ZEGAstraZeneca PLC | 214.38 B EUR | 138.95 EUR | +0.83% | 12 | 0.08 | 28.99 | 4.79 EUR | +24.09% | 2.04% | Health technology | Strong buy |
 NOTNovartis AG | 208.07 B EUR | 109.30 EUR | +0.02% | 35 | 0.07 | 17.20 | 6.35 EUR | −12.24% | 3.43% | Health technology | Neutral |
 NOVNovo Nordisk A/S Class B | 200.96 B EUR | 46.805 EUR | +1.73% | 14.88 K | 0.82 | 14.05 | 3.33 EUR | +23.97% | 3.44% | Health technology | Buy |
 6MKMerck & Co., Inc. | 180.49 B EUR | 72.0 EUR | +0.28% | 20 | 0.08 | 13.08 | 5.51 EUR | +9.30% | 3.78% | Health technology | Buy |
 PFEPfizer Inc. | 119.98 B EUR | 21.095 EUR | −0.21% | 2.83 K | 0.39 | 13.21 | 1.60 EUR | — | 6.92% | Health technology | Neutral |
 SNWSanofi SA | 98.48 B EUR | 80.94 EUR | +0.68% | 15 | 0.00 | 11.00 | 7.36 EUR | +119.29% | 4.85% | Health technology | Buy |
 VX1Vertex Pharmaceuticals Incorporated | 86.81 B EUR | 338.00 EUR | +1.29% | 10 | 0.87 | 28.46 | 11.88 EUR | — | 0.00% | Health technology | Buy |
 BRMBristol-Myers Squibb Company | 82.1 B EUR | 40.305 EUR | +0.37% | 75 | 0.21 | 19.16 | 2.10 EUR | — | 5.21% | Health technology | Neutral |
 GS71GSK plc | 69.33 B EUR | 17.295 EUR | +0.03% | 120 | 0.22 | 17.89 | 0.97 EUR | −16.43% | 4.23% | Health technology | Neutral |
 CUPChugai Pharmaceutical Co., Ltd. | 64.2 B EUR | 38.30 EUR | −1.21% | 0 | 0.00 | 27.06 | 1.42 EUR | +13.12% | 2.70% | Health technology | Buy |
 ZOEZoetis, Inc. Class A | 56.69 B EUR | 128.32 EUR | +0.08% | 50 | 2.29 | 26.01 | 4.93 EUR | +3.48% | 1.29% | Health technology | Buy |
 DULAlnylam Pharmaceuticals, Inc | 53.97 B EUR | 408.1 EUR | +0.12% | 0 | 0.00 | — | −2.09 EUR | −272.81% | 0.00% | Health technology | Buy |
 RGORegeneron Pharmaceuticals, Inc. | 50.37 B EUR | 471.7 EUR | −0.32% | 0 | 0.00 | 14.00 | 33.69 EUR | −4.43% | 0.47% | Health technology | Buy |
 MRKMerck KGaA | 47.56 B EUR | 108.50 EUR | −1.36% | 70 | 0.19 | 16.48 | 6.59 EUR | +9.02% | 2.01% | Health technology | Buy |
 TKDTakeda Pharmaceutical Co. Ltd. | 41.44 B EUR | 26.17 EUR | +0.69% | 0 | 0.00 | 52.50 | 0.50 EUR | −8.58% | 4.34% | Health technology | Buy |
 D4SDaiichi Sankyo Company, Limited | 39.74 B EUR | 20.93 EUR | −2.65% | 250 | 7.79 | 22.59 | 0.93 EUR | +33.73% | 1.63% | Health technology | Strong buy |
 UNCUCB S.A. | 39.56 B EUR | 209.7 EUR | −0.10% | 200 | 5.29 | 30.60 | 6.85 EUR | +458.55% | 0.47% | Health technology | Strong buy |
 H6D0Haleon PLC | 37.22 B EUR | 4.261 EUR | +2.50% | 0 | 0.00 | 21.87 | 0.19 EUR | +39.90% | 1.89% | Health technology | Buy |
 BAYNBayer AG | 27.74 B EUR | 27.830 EUR | −1.68% | 2.77 K | 0.78 | — | −3.48 EUR | −169.98% | 0.39% | Health technology | Buy |
 OS1Otsuka Holdings Co., Ltd. | 26.01 B EUR | 47.2 EUR | −2.48% | 300 | 60.00 | 10.51 | 4.49 EUR | +231.30% | 1.53% | Health technology | Buy |
 3KYHansoh Pharmaceutical Group Company Limited | 25.68 B EUR | 4.14 EUR | +0.98% | 0 | 0.00 | 44.26 | 0.09 EUR | −7.99% | 0.87% | Health technology | Strong buy |
 IDPBiogen Inc. | 17.98 B EUR | 122.25 EUR | +2.69% | 0 | 0.00 | 13.78 | 8.87 EUR | +19.71% | 0.00% | Health technology | Buy |
 YPHAstellas Pharma Inc. | 17.68 B EUR | 9.540 EUR | +0.65% | 0 | — | 35.79 | 0.27 EUR | +377.42% | 4.37% | Health technology | Neutral |
 GE9Genmab A/S | 14.46 B EUR | 237.0 EUR | +0.30% | 0 | 0.00 | 12.94 | 18.32 EUR | +63.28% | 0.00% | Health technology | Buy |
 SH0Shionogi & Co., Ltd. | 13.66 B EUR | 14.7 EUR | −0.68% | 0 | 0.00 | 11.85 | 1.24 EUR | +23.10% | 2.29% | Health technology | Neutral |
 SRTSartorius AG | 12.45 B EUR | 161.4 EUR | +2.80% | 0 | 0.00 | 107.04 | 1.51 EUR | +33.31% | 0.45% | Health technology | Buy |
 VIAViatris, Inc. | 10.4 B EUR | 8.886 EUR | −0.87% | 0 | 0.00 | — | −2.47 EUR | −386.91% | 4.59% | Health technology | Neutral |
 OFKOrion Oyj Class B | 9.21 B EUR | 65.60 EUR | +0.15% | 0 | 0.00 | 24.39 | 2.69 EUR | +62.54% | 2.48% | Health technology | Buy |
 EIIEisai Co., Ltd. | 8.64 B EUR | 29.20 EUR | −2.89% | 1 | 0.00 | 27.81 | 1.05 EUR | +58.99% | 3.02% | Health technology | Buy |
 KY4Kyowa Kirin Co., Ltd. | 7.77 B EUR | 14.5 EUR | −1.36% | 0 | 0.00 | 33.63 | 0.43 EUR | −59.05% | 2.30% | Health technology | Buy |
 ON4ONO Pharmaceutical Co., Ltd. | 4.75 B EUR | 9.95 EUR | 0.00% | 0 | 0.00 | 18.50 | 0.54 EUR | −63.43% | 4.58% | Health technology | Sell |
 22ZZealand Pharma A/S | 4.06 B EUR | 55.94 EUR | −4.93% | 0 | 0.00 | 4.50 | 12.43 EUR | — | 0.00% | Health technology | Strong buy |
 UNJUnited Laboratories International Holdings Ltd. | 3.67 B EUR | 1.81 EUR | +0.56% | 0 | — | 9.21 | 0.20 EUR | −5.08% | 3.62% | Health technology | Buy |
 640China Resources Pharmaceutical Group Ltd. | 3.4 B EUR | 0.525 EUR | 0.00% | 0 | — | 10.05 | 0.05 EUR | −32.54% | 2.97% | Health technology | Buy |
 SZDSanten Pharmaceutical Co., Ltd. | 3.27 B EUR | 9.40 EUR | +0.53% | 0 | — | 17.45 | 0.54 EUR | +24.26% | 2.18% | Health technology | Buy |
 BV3Bavarian Nordic A/S | 2.5 B EUR | 31.49 EUR | +0.45% | 1.23 K | 3.76 | 12.95 | 2.43 EUR | +96.29% | 0.00% | Health technology | Buy |
 LDZAAspen Pharmacare Holdings Limited | 2.29 B EUR | 5.00 EUR | +2.04% | 0 | 0.00 | — | −0.11 EUR | −122.59% | 3.38% | Health technology | Sell |
 DMPDermapharm Holding SE | 1.77 B EUR | 32.40 EUR | −1.82% | 0 | 0.00 | 16.27 | 1.99 EUR | +29.10% | 2.74% | Health technology | Buy |
 EVTEvotec SE | 1.03 B EUR | 5.920 EUR | +2.74% | 850 | 0.16 | — | −0.88 EUR | +9.05% | 0.00% | Health technology | Buy |
 9VCATAI Life Sciences N.V. | 895.11 M EUR | 4.111 EUR | +8.73% | 50 | 0.03 | — | — | — | 0.00% | Health technology | Strong buy |
 6QCTowa Pharmaceutical Co., Ltd. | 865.25 M EUR | 16.7 EUR | −2.34% | 0 | — | 8.72 | 1.92 EUR | −3.93% | 2.31% | Health technology | Strong buy |
 PHGNPharming Group NV | 832.45 M EUR | 1.202 EUR | −2.12% | 0 | 0.00 | — | −0.01 EUR | +38.07% | 0.00% | Health technology | Strong buy |
 MFYMochida Pharmaceutical Co., Ltd. | 642.62 M EUR | 18.4 EUR | 0.00% | 0 | — | 18.38 | 1.00 EUR | +39.01% | 2.45% | Health technology | Neutral |
 JCRJCR Pharmaceuticals Co., Ltd. | 468.11 M EUR | 3.62 EUR | −1.63% | 0 | — | — | −0.27 EUR | −239.88% | 3.06% | Health technology | Neutral |
 FYBFormycon AG | 404.6 M EUR | 22.75 EUR | −0.44% | 0 | 0.00 | — | −9.61 EUR | −338.52% | 0.00% | Health technology | Strong buy |
 25EElan Corp. | 289.64 M EUR | 4.54 EUR | 0.00% | 0 | — | 19.45 | 0.23 EUR | −6.06% | 1.57% | Health technology | Neutral |
 FUPFuji Pharma Co., Ltd. | 227.08 M EUR | 9.20 EUR | 0.00% | 0 | — | 12.40 | 0.74 EUR | −51.14% | 2.83% | Health technology | Strong buy |
 DBVDBV Technologies SA | 206.72 M EUR | 1.454 EUR | +2.97% | 0 | — | — | −1.03 EUR | −20.97% | 0.00% | Health technology | Buy |
 NP5Newron Pharmaceuticals S.p.A. | 198.64 M EUR | 9.79 EUR | −1.11% | 0 | 0.00 | 13.04 | 0.75 EUR | — | 0.00% | Health technology | Strong buy |
 XUPGenfit SA | 176.74 M EUR | 3.454 EUR | +3.10% | 0 | — | — | −0.08 EUR | +86.86% | 0.00% | Health technology | Strong buy |
 HPHAHeidelberg Pharma AG | 166 M EUR | 3.51 EUR | +0.29% | 0 | 0.00 | — | −0.50 EUR | −78.48% | 0.00% | Health technology | Strong buy |
 IDDInnate Pharma SA Class A | 163.32 M EUR | 1.746 EUR | +2.11% | 0 | — | — | −0.61 EUR | −546.61% | 0.00% | Health technology | Strong buy |
 L1PALee's Pharmaceutical Holdings Limited | 134.89 M EUR | 0.226 EUR | +2.73% | 0 | — | 12.59 | 0.02 EUR | +40.27% | 2.15% | Health technology | Neutral |
 APPHAPONTIS PHARMA AG | 91.8 M EUR | 10.75 EUR | +1.90% | 0 | 0.00 | 136.77 | 0.08 EUR | — | 0.00% | Health technology | Neutral |
 PTPPentixapharm Holding AG | 41.64 M EUR | 1.660 EUR | 0.00% | 1 K | 31.75 | — | — | — | 0.00% | Health technology | Neutral |
 B8FKBiofrontera AG | 16.16 M EUR | 2.43 EUR | −2.80% | 0 | 0.00 | — | −0.79 EUR | −1,016.15% | 0.00% | Health technology | Neutral |
 27N0CANNOVUM CANNABIS AG | — | 0.420 EUR | 0.00% | 0 | 0.00 | — | — | — | — | Health technology | Neutral |